<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062786</url>
  </required_header>
  <id_info>
    <org_study_id>7294</org_study_id>
    <nct_id>NCT04062786</nct_id>
  </id_info>
  <brief_title>Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study</brief_title>
  <acronym>PMSF-PVC</acronym>
  <official_title>Postoperative Renal Failure in Cardiac Surgery PMSF-PVC Gradient Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute renal failure is a frequent and severe postoperative complication of cardiac surgery
      performed under extracorporeal circulation.

      It is an independent risk factor for mortality and significantly increases the length of
      hospital stay.

      The origin of renal insufficiency after extracorporeal circulation is multifactorial (long
      duration of extracorporeal circulation, hemodynamic instability per and post-extracorporeal
      circulation, prolonged hypotension, transfusion ...).

      Nevertheless, an entirely different pathophysiological mechanism, though not recent, is less
      often mentioned but shows renewed interest. This is the concept of renal venous congestion
      which may be responsible for impaired renal function in the absence of cardiac dysfunction.
      Based on Guyton's circulatory model, the investigators approach this systemic venous
      hypertension through the measurement of the Pmsf-PVC gradient.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 21, 2019</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Actual">February 21, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evolution of the gradient Pmsf (arm) -PVC</measure>
    <time_frame>24 hours</time_frame>
    <description>Monitor the evolution of the Pmsf (arm) -PVC gradient at H24 and compare this gradient between the two patient populations (with and without postoperative acute renal failure)</description>
  </primary_outcome>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Scheduled Heart Surgery</condition>
  <condition>Valve Replacement</condition>
  <condition>Coronary Artery Bypass</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pmsf-PVC gradient measurement</intervention_name>
    <description>implementation of standard standard hemodynamic monitorin</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Major patient with scheduled heart surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt; 18 years

          -  subject having signed an informed consent

          -  scheduled heart surgery:

               -  Valve replacement

               -  Coronary artery bypass

        Exclusion Criteria:

          -  Any urgent surgery or redux

          -  Severe preoperative chronic renal failure (stage III) defined by GFR &lt;30ml / min

          -  Existence of rhythm disorders (permanent ACFA) or serious cardiac conduction
             disorders, patients with Pacemaker

          -  Preoperative alteration of left ventricular ejection fraction with LVEF &lt;40%

          -  Major haemodynamic instability with refractory shock defined by dobutamine ≥10μg / kg
             / min and / or norepinephrine ≥ 1μg / kg / min and / or epinephrine ≥ 0.2μg / kg /
             min.

          -  Intra-aortic versus assisted pelvic balloon

          -  Contraindication to femoral arterial catheterization

          -  Subject under the protection of justice, subject under guardianship or under tutorship

          -  Impossibility of giving the subject informed information (subject in emergency
             situation, difficulties in understanding the subject)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bob HEGER</last_name>
      <phone>+33 03 69 55 04 44</phone>
      <email>Bob.heger@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Bob HEGER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul Michel MERTES</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annick STEIB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier COLLANGE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michel KINDO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gharib AJOB</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mircea CRISTINAR</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine MARGUERITE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Walid OULEHRI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François LEVY</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François FISCHER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 11, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

